1. Home
  2. ZUMZ vs VCRE Comparison

ZUMZ vs VCRE Comparison

Compare ZUMZ & VCRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

HOLD

Current Price

$13.95

Market Cap

304.2M

ML Signal

HOLD

Logo Vicore Pharma Holding AB American Depositary Shares

VCRE

Vicore Pharma Holding AB American Depositary Shares

N/A

Current Price

$10.32

Market Cap

316.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ZUMZ
VCRE
Founded
1978
N/A
Country
United States
Sweden
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
304.2M
316.4M
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
ZUMZ
VCRE
Price
$13.95
$10.32
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
304.8K
11.3K
Earning Date
06-04-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
966.67
N/A
EPS
N/A
N/A
Revenue
$929,057,000.00
N/A
Revenue This Year
$4.30
N/A
Revenue Next Year
$3.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.48
N/A
52 Week Low
$13.07
$10.03
52 Week High
$31.70
$13.15

Technical Indicators

Market Signals
Indicator
ZUMZ
VCRE
Relative Strength Index (RSI) 30.24 35.15
Support Level N/A N/A
Resistance Level $18.87 $13.00
Average True Range (ATR) 0.68 0.58
MACD -0.35 -0.11
Stochastic Oscillator 16.90 9.91

Price Performance

Historical Comparison
ZUMZ
VCRE

About ZUMZ Zumiez Inc.

Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About VCRE Vicore Pharma Holding AB American Depositary Shares

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

Share on Social Networks: